https://medicaex.com/businesswire/humanetics-corporation-publishes-phase-1-trial-results-for-bio-300-oral-powder-2/ 2022-11-15T15:12:13+00:00 https://medicaex.com/wp-content/uploads/2022/11/humlogo-QTbO4F.jpeg https://medicaex.com/businesswire/advanced-clinical-launches-refreshed-brand-and-website-2/ 2022-11-15T15:12:12+00:00 https://medicaex.com/wp-content/uploads/2022/11/AC_Wordmark_Logo_RGB_200x175-01-1VZxNN.jpeg https://medicaex.com/businesswire/outlook-on-the-software-as-a-medical-device-global-market-to-2029-featuring-qlarity-imaging-arterys-apple-and-idx-technologies-among-others-researchandmarkets-com-2/ 2022-11-15T15:12:10+00:00 https://medicaex.com/wp-content/uploads/2022/11/logo-aQ76jH.jpeg https://medicaex.com/businesswire/worldwide-in-vitro-diagnostics-industry-to-2029-rising-awareness-regarding-diagnosis-of-disease-in-developing-economies-is-driving-growth-researchandmarkets-com/ 2022-11-15T15:12:09+00:00 https://medicaex.com/wp-content/uploads/2022/11/logo-ON3nvA.jpeg https://medicaex.com/businesswire/global-bronchoscopes-market-report-2022-researchandmarkets-com/ 2022-11-15T15:12:08+00:00 https://medicaex.com/wp-content/uploads/2022/11/logo-euFhsW.jpeg https://medicaex.com/businesswire/outlook-on-the-software-as-a-medical-device-global-market-to-2029-featuring-qlarity-imaging-arterys-apple-and-idx-technologies-among-others-researchandmarkets-com/ 2022-11-15T15:12:08+00:00 https://medicaex.com/wp-content/uploads/2022/11/logo-AlRs6I.jpeg https://medicaex.com/businesswire/oncolytic-virus-cancer-therapy-market-insights-epidemiology-and-forecasts-2019-2021-2022-2032-focus-on-united-states-germany-spain-italy-france-united-kingdom-and-japan-researchandma/ 2022-11-15T15:12:05+00:00 https://medicaex.com/wp-content/uploads/2022/11/logo-MayVr2.jpeg https://medicaex.com/businesswire/worldwide-huntingtons-disease-industry-to-2029-a-robust-product-pipeline-of-disease-modifying-treatments-is-expected-to-drive-the-market-researchandmarkets-com/ 2022-11-15T15:12:05+00:00 https://medicaex.com/wp-content/uploads/2022/11/logo-lzkZct.jpeg https://medicaex.com/businesswire/humanetics-corporation-publishes-phase-1-trial-results-for-bio-300-oral-powder/ 2022-11-15T15:12:05+00:00 https://medicaex.com/wp-content/uploads/2022/11/humlogo-1IsFqN.jpeg https://medicaex.com/businesswire/optime-care-recognizes-role-of-caregivers-for-individuals-with-rare-disease-chronic-complex-conditions/ 2022-11-15T15:12:05+00:00 https://medicaex.com/wp-content/uploads/2022/11/OptimeCare-logo_Page_1-ArmtBM.jpeg https://medicaex.com/businesswire/advanced-clinical-launches-refreshed-brand-and-website/ 2022-11-15T15:12:04+00:00 https://medicaex.com/wp-content/uploads/2022/11/AC_Wordmark_Logo_RGB_200x175-01-FL4u56.jpeg https://medicaex.com/businesswire/found-named-a-next-hottest-product-in-amplitudes-product-report-2022/ 2022-11-15T15:12:03+00:00 https://medicaex.com/wp-content/uploads/2022/11/Found_Primary_Logo_Pine_Green-Mo1mwE.jpeg https://medicaex.com/businesswire/garuda-therapeutics-announces-appointment-of-david-digiusto-ph-d-as-chief-technology-officer-2/ 2022-11-15T14:12:15+00:00 https://medicaex.com/wp-content/uploads/2022/11/Garuda_Tx_Logo-x7T23V.jpeg https://medicaex.com/businesswire/propanc-biopharmas-cso-predicts-prp-could-enhance-therapeutic-effects-of-immune-checkpoint-therapy-for-pancreatic-cancer-2/ 2022-11-15T14:12:15+00:00 https://medicaex.com/wp-content/uploads/2022/11/propanc-logo-XtNfFO.jpeg https://medicaex.com/businesswire/digital-marketing-competency-report-reveals-2022-ranking-of-biopharma-brands-based-on-digital-patient-experiences-3/ 2022-11-15T14:12:15+00:00 https://medicaex.com/wp-content/uploads/2022/11/trinity-logo-530_x_146-zpsp4L.jpeg https://medicaex.com/businesswire/rockley-photonics-to-present-at-upcoming-conferences/ 2022-11-15T14:12:14+00:00 https://medicaex.com/wp-content/uploads/2022/11/Rockley-logo-500-x-500-YOT9pp.jpeg https://medicaex.com/businesswire/first-completion-of-a-full-treatment-workflow-in-the-first-european-hospital-based-bnct-facility/ 2022-11-15T14:12:14+00:00 https://medicaex.com/wp-content/uploads/2022/11/NTI_Logo_RGB-Cjnl1G.jpeg https://medicaex.com/businesswire/franklys-online-wellness-coaching-now-available-nationwide-2/ 2022-11-15T14:12:11+00:00 https://medicaex.com/wp-content/uploads/2022/11/Frankly_OrangeMedium-uy6nnv.jpeg https://medicaex.com/businesswire/baxter-declares-quarterly-dividend-2/ 2022-11-15T14:12:11+00:00 https://medicaex.com/businesswire/garuda-therapeutics-announces-appointment-of-david-digiusto-ph-d-as-chief-technology-officer/ 2022-11-15T14:12:11+00:00 https://medicaex.com/wp-content/uploads/2022/11/Garuda_Tx_Logo-PAN2YX.jpeg https://medicaex.com/businesswire/asante-announces-partnership-with-edgility-inc/ 2022-11-15T14:12:11+00:00 https://medicaex.com/wp-content/uploads/2022/11/EdgilityLogo-DqNJ8x.jpeg https://medicaex.com/businesswire/model-n-fall-2022-product-offering-addresses-dynamic-market-needs-2/ 2022-11-15T14:12:10+00:00 https://medicaex.com/wp-content/uploads/2022/11/Model_N_Logo-icgfgQ.jpeg https://medicaex.com/businesswire/better-health-expands-care-to-more-people-with-chronic-conditions-2/ 2022-11-15T14:12:09+00:00 https://medicaex.com/wp-content/uploads/2022/11/Better_Health_-_Logo_1_2800229-zCrx5w.jpeg https://medicaex.com/businesswire/penumbra-launches-first-hands-free-full-body-virtual-reality-based-offering-for-rehabilitation-expanding-real-system-platform/ 2022-11-15T14:12:09+00:00 https://medicaex.com/wp-content/uploads/2022/11/25139A_REAL_y-Series_Sizzle_Video_USA-FjEuWO.jpeg https://medicaex.com/businesswire/global-covid-19-vaccine-market-forecast-to-2029-researchandmarkets-com-2/ 2022-11-15T14:12:09+00:00 https://medicaex.com/wp-content/uploads/2022/11/logo-2Dhq3r.jpeg https://medicaex.com/businesswire/baxter-declares-quarterly-dividend/ 2022-11-15T14:12:09+00:00 https://medicaex.com/businesswire/global-healthcare-supply-chain-management-market-report-2022-need-for-improved-operational-efficiency-and-profitability-drives-growth-researchandmarkets-com/ 2022-11-15T14:12:08+00:00 https://medicaex.com/wp-content/uploads/2022/11/logo-DZ5ofO.jpeg https://medicaex.com/businesswire/aetrexs-albert-2-pro-and-orthotics-help-denver-fire-department-reduce-injuries-improve-comfort-and-performance/ 2022-11-15T14:12:08+00:00 https://medicaex.com/wp-content/uploads/2022/11/DFD_using_Albert_2_Pro-DW8tCb.jpeg https://medicaex.com/businesswire/global-covid-19-vaccine-market-forecast-to-2029-researchandmarkets-com/ 2022-11-15T14:12:07+00:00 https://medicaex.com/wp-content/uploads/2022/11/logo-9Gd8ub.jpeg https://medicaex.com/businesswire/better-health-expands-care-to-more-people-with-chronic-conditions/ 2022-11-15T14:12:07+00:00 https://medicaex.com/wp-content/uploads/2022/11/Better_Health_-_Logo_1_2800229-k7CdBm.jpeg https://medicaex.com/businesswire/lionel-bonte-named-new-president-of-mativs-healthcare-and-wellness-business-unit/ 2022-11-15T14:12:07+00:00 https://medicaex.com/wp-content/uploads/2022/11/Mativ_Logo_Grey-RXCHUn.jpeg https://medicaex.com/businesswire/propanc-biopharmas-cso-predicts-prp-could-enhance-therapeutic-effects-of-immune-checkpoint-therapy-for-pancreatic-cancer/ 2022-11-15T14:12:05+00:00 https://medicaex.com/wp-content/uploads/2022/11/propanc-logo-ZZEQ4U.jpeg https://medicaex.com/businesswire/endevica-reports-positive-tcmcb07-data-from-single-ascending-dose-portion-of-phase-1-clinical-trial-in-cachexia/ 2022-11-15T14:12:05+00:00 https://medicaex.com/wp-content/uploads/2022/11/ENDEVICA_BIO_LOGO-01-L2vKic.jpeg https://medicaex.com/businesswire/digital-marketing-competency-report-reveals-2022-ranking-of-biopharma-brands-based-on-digital-patient-experiences-2/ 2022-11-15T14:12:05+00:00 https://medicaex.com/wp-content/uploads/2022/11/trinity-logo-530_x_146-FnE3qp.jpeg https://medicaex.com/businesswire/epic-bio-to-participate-in-the-bmo-virtual-spotlight-series/ 2022-11-15T14:12:05+00:00 https://medicaex.com/wp-content/uploads/2022/11/EpicBioCMYK300dpi-4HQk2N.jpeg https://medicaex.com/businesswire/digital-marketing-competency-report-reveals-2022-ranking-of-biopharma-brands-based-on-digital-patient-experiences/ 2022-11-15T14:12:04+00:00 https://medicaex.com/wp-content/uploads/2022/11/trinity-logo-530_x_146-6dcHIh.jpeg https://medicaex.com/businesswire/model-n-fall-2022-product-offering-addresses-dynamic-market-needs/ 2022-11-15T14:12:04+00:00 https://medicaex.com/wp-content/uploads/2022/11/Model_N_Logo-xre1j2.jpeg https://medicaex.com/businesswire/franklys-online-wellness-coaching-now-available-nationwide/ 2022-11-15T14:12:03+00:00 https://medicaex.com/wp-content/uploads/2022/11/Frankly_OrangeMedium-12zVhA.jpeg https://medicaex.com/businesswire/included-health-announces-all-included-care-on-stage-at-hlth/ 2022-11-15T14:12:03+00:00 https://medicaex.com/wp-content/uploads/2022/11/Included_Logo_FullColor_Screen_28129-hKhmcf.jpeg https://medicaex.com/businesswire/maia-biotechnology-presents-preclinical-data-at-sitc-annual-meeting-validating-efficacy-of-thio-in-treating-hepatocellular-carcinoma-2/ 2022-11-15T13:12:16+00:00 https://medicaex.com/wp-content/uploads/2022/11/download-LxEweo.jpeg https://medicaex.com/businesswire/innovative-oncology-cro-oncobay-clinical-joins-physiq-intrepid-partner-program-3/ 2022-11-15T13:12:15+00:00 https://medicaex.com/wp-content/uploads/2022/11/physIQ-2022-Logo-2Colors-RGB-Web-pS73fZ.jpeg https://medicaex.com/businesswire/scholar-rock-announces-new-employment-inducement-grant-under-nasdaq-listing-rule-5635c4-2/ 2022-11-15T13:12:15+00:00 https://medicaex.com/wp-content/uploads/2022/11/Scholar_Rock_Logo-8C5Hm3.jpeg https://medicaex.com/businesswire/lucy-therapeutics-expands-leadership-team-with-appointment-of-julia-gaebler-ph-d-as-chief-business-officer-2/ 2022-11-15T13:12:15+00:00 https://medicaex.com/wp-content/uploads/2022/11/GAEBLER_Headshot1000pixH-eV5kU6.jpeg https://medicaex.com/businesswire/exscientia-business-and-financial-update-for-the-third-quarter-2022/ 2022-11-15T13:12:15+00:00 https://medicaex.com/wp-content/uploads/2022/11/Exscientia_Logo-YMmL8n.jpeg https://medicaex.com/businesswire/elevatebio-and-affini-t-therapeutics-announce-partnership-to-advance-affini-ts-t-cell-therapy-programs-targeting-core-oncogenic-drivers/ 2022-11-15T13:12:12+00:00 https://medicaex.com/wp-content/uploads/2022/11/Elevatebio_logo-iJe7M9.jpeg https://medicaex.com/businesswire/better-therapeutics-to-participate-in-btig-digital-health-forum-2/ 2022-11-15T13:12:12+00:00 https://medicaex.com/wp-content/uploads/2022/11/Better_Tx_640x360_Logo-616Vf5.jpeg https://medicaex.com/businesswire/advanced-energy-introduces-first-fully-integrated-intelligent-configurable-capacitor-charger-for-surgical-and-aesthetic-laser-applications-2/ 2022-11-15T13:12:11+00:00 https://medicaex.com/wp-content/uploads/2022/11/AEI_Cap_Charger_FL_W-OWNse5.jpeg https://medicaex.com/businesswire/change-healthcare-expands-functionality-and-drives-industry-transition-to-cloud-based-imaging-and-storage-2/ 2022-11-15T13:12:11+00:00 https://medicaex.com/wp-content/uploads/2022/11/CHC_Logo_Rev_Facebook_KO_400x400-A9Uonz.jpeg https://medicaex.com/businesswire/everly-health-unveils-spotwell-technology-in-new-mobile-app/ 2022-11-15T13:12:11+00:00 https://medicaex.com/wp-content/uploads/2022/11/EverlyHealth_logo_Logo-SkYmUj.jpeg https://medicaex.com/businesswire/change-healthcare-expands-functionality-and-drives-industry-transition-to-cloud-based-imaging-and-storage/ 2022-11-15T13:12:10+00:00 https://medicaex.com/wp-content/uploads/2022/11/CHC_Logo_Rev_Facebook_KO_400x400-6D6UcX.jpeg https://medicaex.com/businesswire/soundbite-medical-enters-into-a-license-agreement-with-vflo-medical-to-bring-its-products-to-greater-china/ 2022-11-15T13:12:09+00:00 https://medicaex.com/wp-content/uploads/2022/11/sb_logo_coul_CMYK_uncoated_28129_highres-OFeTV0.jpeg https://medicaex.com/businesswire/innovative-oncology-cro-oncobay-clinical-joins-physiq-intrepid-partner-program-2/ 2022-11-15T13:12:09+00:00 https://medicaex.com/wp-content/uploads/2022/11/physIQ-2022-Logo-2Colors-RGB-Web-DdNzxo.jpeg https://medicaex.com/businesswire/northstar-medical-radioisotopes-expands-business-platform-with-new-patient-focused-radiopharmaceutical-contract-development-and-manufacturing-organization-cdmo-services-unit-2/ 2022-11-15T13:12:09+00:00 https://medicaex.com/wp-content/uploads/2022/11/NorthStar_Radiopharmaceutical_CDMO_Artist_Rendering_10-6-22-TjuM3a.jpeg https://medicaex.com/businesswire/advanced-energy-introduces-first-fully-integrated-intelligent-configurable-capacitor-charger-for-surgical-and-aesthetic-laser-applications/ 2022-11-15T13:12:09+00:00 https://medicaex.com/wp-content/uploads/2022/11/AEI_Cap_Charger_FL_W-CfSrFQ.jpeg https://medicaex.com/businesswire/northstar-medical-radioisotopes-expands-business-platform-with-new-patient-focused-radiopharmaceutical-contract-development-and-manufacturing-organization-cdmo-services-unit/ 2022-11-15T13:12:06+00:00 https://medicaex.com/wp-content/uploads/2022/11/NorthStar_Radiopharmaceutical_CDMO_Artist_Rendering_10-6-22-XbrdDk.jpeg https://medicaex.com/businesswire/maia-biotechnology-presents-preclinical-data-at-sitc-annual-meeting-validating-efficacy-of-thio-in-treating-hepatocellular-carcinoma/ 2022-11-15T13:12:05+00:00 https://medicaex.com/wp-content/uploads/2022/11/download-ZwM5Np.jpeg https://medicaex.com/businesswire/scholar-rock-announces-new-employment-inducement-grant-under-nasdaq-listing-rule-5635c4/ 2022-11-15T13:12:05+00:00 https://medicaex.com/wp-content/uploads/2022/11/Scholar_Rock_Logo-VrKhSw.jpeg https://medicaex.com/businesswire/lucy-therapeutics-expands-leadership-team-with-appointment-of-julia-gaebler-ph-d-as-chief-business-officer/ 2022-11-15T13:12:05+00:00 https://medicaex.com/wp-content/uploads/2022/11/GAEBLER_Headshot1000pixH-QZRImh.jpeg https://medicaex.com/businesswire/innovative-oncology-cro-oncobay-clinical-joins-physiq-intrepid-partner-program/ 2022-11-15T13:12:04+00:00 https://medicaex.com/wp-content/uploads/2022/11/physIQ-2022-Logo-2Colors-RGB-Web-IAjY8w.jpeg https://medicaex.com/businesswire/better-therapeutics-to-participate-in-btig-digital-health-forum/ 2022-11-15T13:12:03+00:00 https://medicaex.com/wp-content/uploads/2022/11/Better_Tx_640x360_Logo-Vck04v.jpeg https://medicaex.com/businesswire/medidata-launches-rave-companion-the-first-scalable-solution-for-automating-ehr-data-entry-into-rave-edc-3/ 2022-11-15T12:12:13+00:00 https://medicaex.com/wp-content/uploads/2022/11/3DS_MEDIDATA_Logotype_RGB_PRIMARY_28129-FEE1Gz.jpeg https://medicaex.com/businesswire/antibe-reports-q2-2023-interim-financial-and-operating-results/ 2022-11-15T12:12:13+00:00 https://medicaex.com/wp-content/uploads/2022/11/ANTIBE-logo-RGB-qDCrd5.jpeg https://medicaex.com/businesswire/omniab-reports-third-quarter-2022-financial-results-and-business-highlights-2/ 2022-11-15T12:12:13+00:00 https://medicaex.com/businesswire/casma-therapeutics-raises-46-0-m-in-series-c-funding-2/ 2022-11-15T12:12:13+00:00 https://medicaex.com/wp-content/uploads/2022/11/Casma-FullLogotype_PositiveFullColorRGB-5KLmpQ.jpeg https://medicaex.com/businesswire/castle-biosciences-presents-new-data-demonstrating-the-clinical-utility-and-value-of-decisiondx-scc-in-moderately-and-poorly-differentiated-cutaneous-squamous-cell-carcinoma-tumors-2/ 2022-11-15T12:12:13+00:00 https://medicaex.com/wp-content/uploads/2022/11/CastleLogo2Color-joz6NL.jpeg https://medicaex.com/businesswire/university-of-denver-study-shows-king-devick-test-in-association-with-mayo-clinic-is-an-accurate-tool-for-detecting-tracking-and-measuring-the-severity-of-long-covid-2/ 2022-11-15T12:12:10+00:00 https://medicaex.com/wp-content/uploads/2022/11/KDT_Logo_Horizontal-EGXq8C.jpeg https://medicaex.com/businesswire/beigene-launches-talk-about-it-program-to-elevate-the-importance-of-addressing-mental-health-during-cancer-care/ 2022-11-15T12:12:10+00:00 https://medicaex.com/wp-content/uploads/2022/11/BGNE-LOGO-HORTZ-COLOR-BREDMID-RGB-5MEZNr.jpeg https://medicaex.com/businesswire/bonum-therapeutics-announces-a-93m-series-a-financing-to-advance-a-novel-and-validated-class-of-conditionally-active-therapies/ 2022-11-15T12:12:10+00:00 https://medicaex.com/wp-content/uploads/2022/11/BONUM-Logo-HB-WTbg-GBYcyH.jpeg https://medicaex.com/businesswire/conmed-corporation-withdraws-2022-financial-outlook-due-to-temporary-impact-from-software-implementation-provides-2023-financial-outlook-2/ 2022-11-15T12:12:09+00:00 https://medicaex.com/wp-content/uploads/2022/11/ConMed_LogoPMS3005_RGB-ciKOeF.jpeg https://medicaex.com/businesswire/medidata-launches-rave-companion-the-first-scalable-solution-for-automating-ehr-data-entry-into-rave-edc-2/ 2022-11-15T12:12:08+00:00 https://medicaex.com/wp-content/uploads/2022/11/3DS_MEDIDATA_Logotype_RGB_PRIMARY_28129-WjeMU0.jpeg https://medicaex.com/businesswire/gabelli-funds-and-columbia-business-school-to-host-4th-annual-healthcare-symposium-2/ 2022-11-15T12:12:08+00:00 https://medicaex.com/businesswire/dalia-dawoud-md-named-co-chair-of-the-american-society-of-diagnostic-and-interventional-nephrologys-19th-annual-scientific-meeting/ 2022-11-15T12:12:08+00:00 https://medicaex.com/wp-content/uploads/2022/11/200dpi_NNA_Final_PRIMARY_Logo_2022-Z2Is32.jpeg https://medicaex.com/businesswire/conmed-corporation-withdraws-2022-financial-outlook-due-to-temporary-impact-from-software-implementation-provides-2023-financial-outlook/ 2022-11-15T12:12:08+00:00 https://medicaex.com/wp-content/uploads/2022/11/ConMed_LogoPMS3005_RGB-FiWjs8.jpeg https://medicaex.com/businesswire/medidata-launches-rave-companion-the-first-scalable-solution-for-automating-ehr-data-entry-into-rave-edc/ 2022-11-15T12:12:05+00:00 https://medicaex.com/wp-content/uploads/2022/11/3DS_MEDIDATA_Logotype_RGB_PRIMARY_28129-G4EnbK.jpeg https://medicaex.com/businesswire/omniab-reports-third-quarter-2022-financial-results-and-business-highlights/ 2022-11-15T12:12:05+00:00 https://medicaex.com/businesswire/casma-therapeutics-raises-46-0-m-in-series-c-funding/ 2022-11-15T12:12:05+00:00 https://medicaex.com/wp-content/uploads/2022/11/Casma-FullLogotype_PositiveFullColorRGB-UmOIrP.jpeg https://medicaex.com/businesswire/castle-biosciences-presents-new-data-demonstrating-the-clinical-utility-and-value-of-decisiondx-scc-in-moderately-and-poorly-differentiated-cutaneous-squamous-cell-carcinoma-tumors/ 2022-11-15T12:12:05+00:00 https://medicaex.com/wp-content/uploads/2022/11/CastleLogo2Color-tAdhl7.jpeg https://medicaex.com/businesswire/genestra-brands-introduces-two-new-vitamin-d-supplements-with-increased-levels-of-vitamin-d/ 2022-11-15T12:12:04+00:00 https://medicaex.com/wp-content/uploads/2022/11/Genestra_Logo_stacked_CMYK_28129-DKuA2B.jpeg https://medicaex.com/businesswire/university-of-denver-study-shows-king-devick-test-in-association-with-mayo-clinic-is-an-accurate-tool-for-detecting-tracking-and-measuring-the-severity-of-long-covid/ 2022-11-15T12:12:03+00:00 https://medicaex.com/wp-content/uploads/2022/11/KDT_Logo_Horizontal-RsJ9aD.jpeg https://medicaex.com/businesswire/avanzanite-bioscience-launches-novel-business-model-to-commercialize-innovative-medicines-for-rare-diseases-in-europe-2/ 2022-11-15T11:12:11+00:00 https://medicaex.com/wp-content/uploads/2022/11/AVANZANITE_FINAL_14NOV_V3-2DUINZ.jpeg https://medicaex.com/businesswire/ablexis-and-alivamab-discovery-services-announce-expansion-of-antibody-drug-discovery-and-engineering-capabilities-2/ 2022-11-15T11:12:11+00:00 https://medicaex.com/wp-content/uploads/2022/11/AlivaMab_Logo-W8A1Qn.jpeg https://medicaex.com/businesswire/ablexis-and-alivamab-discovery-services-announce-expansion-of-antibody-drug-discovery-and-engineering-capabilities/ 2022-11-15T11:12:05+00:00 https://medicaex.com/wp-content/uploads/2022/11/AlivaMab_Logo-rmH668.jpeg https://medicaex.com/businesswire/avanzanite-bioscience-launches-novel-business-model-to-commercialize-innovative-medicines-for-rare-diseases-in-europe/ 2022-11-15T11:12:04+00:00 https://medicaex.com/wp-content/uploads/2022/11/AVANZANITE_FINAL_14NOV_V3-cxupZB.jpeg https://medicaex.com/businesswire/alira-health-partners-with-policy-matters-to-foster-market-access-in-the-uk-3/ 2022-11-15T09:12:10+00:00 https://medicaex.com/wp-content/uploads/2022/11/AliraHealth_L-ebhLcB.jpeg https://medicaex.com/businesswire/alira-health-partners-with-policy-matters-to-foster-market-access-in-the-uk-2/ 2022-11-15T09:12:07+00:00 https://medicaex.com/wp-content/uploads/2022/11/AliraHealth_L-N4S9Vx.jpeg https://medicaex.com/businesswire/alira-health-partners-with-policy-matters-to-foster-market-access-in-the-uk/ 2022-11-15T09:12:04+00:00 https://medicaex.com/wp-content/uploads/2022/11/AliraHealth_L-9nMMfM.jpeg https://medicaex.com/businesswire/slingshot-biosciences-inc-partners-with-palex-medical-to-distribute-synthetic-cells-throughout-spain-and-portugal-3/ 2022-11-15T08:12:11+00:00 https://medicaex.com/wp-content/uploads/2022/11/Slingshot_Biosciences_logo-nKa3tF.jpeg https://medicaex.com/businesswire/slingshot-biosciences-inc-partners-with-palex-medical-to-distribute-synthetic-cells-throughout-spain-and-portugal-2/ 2022-11-15T08:12:07+00:00 https://medicaex.com/wp-content/uploads/2022/11/Slingshot_Biosciences_logo-ZyJIAD.jpeg https://medicaex.com/businesswire/slingshot-biosciences-inc-partners-with-palex-medical-to-distribute-synthetic-cells-throughout-spain-and-portugal/ 2022-11-15T08:12:05+00:00 https://medicaex.com/wp-content/uploads/2022/11/Slingshot_Biosciences_logo-Cdo2e4.jpeg https://medicaex.com/businesswire/juniper-research-precision-medicine-spend-to-exceed-132-billion-globally-by-2027-driven-by-efficiency-gains-for-healthcare-providers-3/ 2022-11-15T07:12:10+00:00 https://medicaex.com/wp-content/uploads/2022/11/Juniper_Research_Logo_2022-aMc4RW.jpeg https://medicaex.com/businesswire/beckley-psytech-successfully-completes-phase-i-clinical-study-of-lead-candidate-bpl-003-a-novel-benzoate-formulation-of-5-meo-dmt-2/ 2022-11-15T07:12:10+00:00 https://medicaex.com/wp-content/uploads/2022/11/Beckley_Psytech_Logo_high_res-f6mEyv.jpeg https://medicaex.com/businesswire/juniper-research-precision-medicine-spend-to-exceed-132-billion-globally-by-2027-driven-by-efficiency-gains-for-healthcare-providers-2/ 2022-11-15T07:12:06+00:00 https://medicaex.com/wp-content/uploads/2022/11/Juniper_Research_Logo_2022-983Hzc.jpeg https://medicaex.com/businesswire/beckley-psytech-successfully-completes-phase-i-clinical-study-of-lead-candidate-bpl-003-a-novel-benzoate-formulation-of-5-meo-dmt/ 2022-11-15T07:12:04+00:00 https://medicaex.com/wp-content/uploads/2022/11/Beckley_Psytech_Logo_high_res-I38ncq.jpeg https://medicaex.com/businesswire/juniper-research-precision-medicine-spend-to-exceed-132-billion-globally-by-2027-driven-by-efficiency-gains-for-healthcare-providers/ 2022-11-15T07:12:03+00:00 https://medicaex.com/wp-content/uploads/2022/11/Juniper_Research_Logo_2022-UpHqqt.jpeg https://medicaex.com/businesswire/biomind-labs-announces-fda-investigational-new-drug-clearance-for-its-new-chemical-entity-triptax-targeting-treatment-resistant-depression-and-reports-third-quarter-financial-results-2/ 2022-11-15T03:12:10+00:00 https://medicaex.com/wp-content/uploads/2022/11/Biomind_Logo_2022-yuIEKT.jpeg https://medicaex.com/businesswire/biomind-labs-announces-fda-investigational-new-drug-clearance-for-its-new-chemical-entity-triptax-targeting-treatment-resistant-depression-and-reports-third-quarter-financial-results/ 2022-11-15T03:12:04+00:00 https://medicaex.com/wp-content/uploads/2022/11/Biomind_Logo_2022-LtThDB.jpeg https://medicaex.com/businesswire/merit-awards-announces-winners-of-2022-healthcare-awards-2/ 2022-11-15T01:12:40+00:00 https://medicaex.com/businesswire/merit-awards-announces-winners-of-2022-healthcare-awards/ 2022-11-15T01:12:32+00:00 https://medicaex.com/businesswire/applied-uv-reports-financial-results-for-third-quarter-2022-2/ 2022-11-15T00:12:08+00:00 https://medicaex.com/businesswire/applied-uv-reports-financial-results-for-third-quarter-2022/ 2022-11-15T00:12:06+00:00 https://medicaex.com/businesswire/correcting-and-replacing-navidea-biopharmaceuticals-reports-third-quarter-2022-financial-results-2/ 2022-11-14T23:12:11+00:00 https://medicaex.com/wp-content/uploads/2022/11/navidea_cmyk-sExR4S.jpeg https://medicaex.com/businesswire/ra-medical-systems-reports-third-quarter-2022-financial-results/ 2022-11-14T23:12:07+00:00 https://medicaex.com/businesswire/correcting-and-replacing-navidea-biopharmaceuticals-reports-third-quarter-2022-financial-results/ 2022-11-14T23:12:04+00:00 https://medicaex.com/wp-content/uploads/2022/11/navidea_cmyk-e3vdSE.jpeg https://medicaex.com/businesswire/arrowhead-pharmaceuticals-to-webcast-fiscal-2022-year-end-results-2/ 2022-11-14T22:12:13+00:00 https://medicaex.com/wp-content/uploads/2022/11/ah_logo_cmyk-4X6ebK.jpeg https://medicaex.com/businesswire/lucid-diagnostics-provides-business-update-and-third-quarter-2022-financial-results-3/ 2022-11-14T22:12:13+00:00 https://medicaex.com/wp-content/uploads/2022/11/LUCD_Logo-cg6q6K.jpeg https://medicaex.com/businesswire/immunogen-announces-fda-accelerated-approval-of-elahere-mirvetuximab-soravtansine-gynx-for-the-treatment-of-platinum-resistant-ovarian-cancer-2/ 2022-11-14T22:12:13+00:00 https://medicaex.com/wp-content/uploads/2022/11/imgnlogo-u7TbXv.jpeg https://medicaex.com/businesswire/cybin-inc-reports-second-quarter-financial-results-and-recent-business-highlights-2/ 2022-11-14T22:12:12+00:00 https://medicaex.com/wp-content/uploads/2022/11/Cybin_Primary_Logo_Blue_Final-3Cir3r.jpeg https://medicaex.com/businesswire/vivani-medical-reports-third-quarter-2022-results-and-provides-business-updates-3/ 2022-11-14T22:12:12+00:00 https://medicaex.com/wp-content/uploads/2022/11/Vivani_Logo-eLD1C0.jpeg https://medicaex.com/businesswire/vivani-medical-reports-third-quarter-2022-results-and-provides-business-updates-2/ 2022-11-14T22:12:08+00:00 https://medicaex.com/wp-content/uploads/2022/11/Vivani_Logo-moAKUC.jpeg https://medicaex.com/businesswire/lucid-diagnostics-provides-business-update-and-third-quarter-2022-financial-results-2/ 2022-11-14T22:12:08+00:00 https://medicaex.com/wp-content/uploads/2022/11/LUCD_Logo-m2x0nL.jpeg https://medicaex.com/businesswire/insulet-issues-a-nationwide-voluntary-medical-device-correction-for-the-omnipod-5-controller/ 2022-11-14T22:12:08+00:00 https://medicaex.com/wp-content/uploads/2022/11/Insulet_Logo-7wctk4.jpeg https://medicaex.com/businesswire/retractable-technologies-inc-results-for-the-periods-ended-september-30-2022-2/ 2022-11-14T22:12:07+00:00 https://medicaex.com/businesswire/retractable-technologies-inc-results-for-the-periods-ended-september-30-2022/ 2022-11-14T22:12:06+00:00 https://medicaex.com/businesswire/immunogen-announces-fda-accelerated-approval-of-elahere-mirvetuximab-soravtansine-gynx-for-the-treatment-of-platinum-resistant-ovarian-cancer/ 2022-11-14T22:12:05+00:00 https://medicaex.com/wp-content/uploads/2022/11/imgnlogo-flXreE.jpeg https://medicaex.com/businesswire/arrowhead-pharmaceuticals-to-webcast-fiscal-2022-year-end-results/ 2022-11-14T22:12:05+00:00 https://medicaex.com/wp-content/uploads/2022/11/ah_logo_cmyk-jr7ey3.jpeg https://medicaex.com/businesswire/cybin-inc-reports-second-quarter-financial-results-and-recent-business-highlights/ 2022-11-14T22:12:04+00:00 https://medicaex.com/wp-content/uploads/2022/11/Cybin_Primary_Logo_Blue_Final-XhIZPf.jpeg https://medicaex.com/businesswire/vivani-medical-reports-third-quarter-2022-results-and-provides-business-updates/ 2022-11-14T22:12:04+00:00 https://medicaex.com/wp-content/uploads/2022/11/Vivani_Logo-wK5cZn.jpeg https://medicaex.com/businesswire/lucid-diagnostics-provides-business-update-and-third-quarter-2022-financial-results/ 2022-11-14T22:12:04+00:00 https://medicaex.com/wp-content/uploads/2022/11/LUCD_Logo-pP7I5A.jpeg https://medicaex.com/businesswire/alpine-immune-sciences-provides-corporate-update-and-reports-third-quarter-2022-financial-results/ 2022-11-14T21:12:14+00:00 https://medicaex.com/wp-content/uploads/2022/11/AIS-Logo-hHeOUF.jpeg https://medicaex.com/businesswire/pear-therapeutics-reports-third-quarter-2022-results-2/ 2022-11-14T21:12:14+00:00 https://medicaex.com/wp-content/uploads/2022/11/Logo-Pear-Therapeutics-Final-ffb5pj.jpeg https://medicaex.com/businesswire/arcus-biosciences-to-participate-in-the-5th-annual-evercore-isi-healthconx-conference-2/ 2022-11-14T21:12:14+00:00 https://medicaex.com/wp-content/uploads/2022/11/ARCUS_Logo_RGB_1920x1080-L79BwT.jpeg https://medicaex.com/businesswire/novabay-pharmaceuticals-reports-third-quarter-2022-financial-results-2/ 2022-11-14T21:12:14+00:00 https://medicaex.com/businesswire/mei-pharma-reports-first-quarter-fiscal-year-2023-results-and-operational-highlights/ 2022-11-14T21:12:14+00:00 https://medicaex.com/businesswire/better-therapeutics-reports-third-quarter-2022-financial-results-and-provides-business-updates-2/ 2022-11-14T21:12:10+00:00 https://medicaex.com/wp-content/uploads/2022/11/Better_Tx_640x360_Logo-dRD49t.jpeg https://medicaex.com/businesswire/nymbl-science-announces-12-million-series-b-funding-round-led-by-cobalt-ventures/ 2022-11-14T21:12:10+00:00 https://medicaex.com/wp-content/uploads/2022/11/nymbl-logo-2020-gray-text-JSYUXh.jpeg https://medicaex.com/businesswire/endra-life-sciences-reports-third-quarter-2022-financial-results-and-provides-business-update/ 2022-11-14T21:12:09+00:00 https://medicaex.com/businesswire/pear-therapeutics-reports-third-quarter-2022-results/ 2022-11-14T21:12:09+00:00 https://medicaex.com/wp-content/uploads/2022/11/Logo-Pear-Therapeutics-Final-9GaAek.jpeg https://medicaex.com/businesswire/exicure-inc-reports-third-quarter-2022-financial-results-and-provides-corporate-update/ 2022-11-14T21:12:09+00:00 https://medicaex.com/wp-content/uploads/2022/11/Exicure_Logo_FINAL_Full_Color-072515-ckSRwN.jpeg https://medicaex.com/businesswire/better-therapeutics-reports-third-quarter-2022-financial-results-and-provides-business-updates/ 2022-11-14T21:12:08+00:00 https://medicaex.com/wp-content/uploads/2022/11/Better_Tx_640x360_Logo-XlWdC1.jpeg https://medicaex.com/businesswire/harrow-announces-third-quarter-2022-financial-results/ 2022-11-14T21:12:06+00:00 https://medicaex.com/wp-content/uploads/2022/11/HROW_3Q22_Letter_to_Shareholders-TRwdEz.jpeg https://medicaex.com/businesswire/novabay-pharmaceuticals-reports-third-quarter-2022-financial-results/ 2022-11-14T21:12:06+00:00 https://medicaex.com/businesswire/arcus-biosciences-to-participate-in-the-5th-annual-evercore-isi-healthconx-conference/ 2022-11-14T21:12:05+00:00 https://medicaex.com/wp-content/uploads/2022/11/ARCUS_Logo_RGB_1920x1080-e3vF9T.jpeg https://medicaex.com/businesswire/therapeuticsmd-announces-third-quarter-2022-financial-results/ 2022-11-14T21:12:05+00:00 https://medicaex.com/wp-content/uploads/2022/11/TXMD_logo-cwv3w2.jpeg https://medicaex.com/businesswire/tricida-announces-third-quarter-2022-financial-results/ 2022-11-14T21:12:05+00:00 https://medicaex.com/wp-content/uploads/2022/11/Tricida_Logo-vector-alt.clr_current_colors_092518-CwkQFk.jpeg https://medicaex.com/businesswire/biointellisense-joins-polaris-dawn-mission-to-advance-understanding-of-human-health-in-space-3/ 2022-11-14T19:12:12+00:00 https://medicaex.com/wp-content/uploads/2022/11/BioIntelliSense_Logo-D0B9XD.jpeg https://medicaex.com/businesswire/global-collagen-markets-analysis-report-2022-focus-on-nutraceuticals-food-and-beverage-pharmaceutical-and-healthcare-cosmetics-and-personal-care-researchandmarkets-com-3/ 2022-11-14T19:12:12+00:00 https://medicaex.com/wp-content/uploads/2022/11/logo-NpP1LL.jpeg https://medicaex.com/businesswire/biointellisense-joins-polaris-dawn-mission-to-advance-understanding-of-human-health-in-space-2/ 2022-11-14T19:12:10+00:00 https://medicaex.com/wp-content/uploads/2022/11/BioIntelliSense_Logo-p8L0wX.jpeg https://medicaex.com/businesswire/biointellisense-joins-polaris-dawn-mission-to-advance-understanding-of-human-health-in-space/ 2022-11-14T19:12:09+00:00 https://medicaex.com/wp-content/uploads/2022/11/BioIntelliSense_Logo-UrVGQ9.jpeg https://medicaex.com/businesswire/global-collagen-markets-analysis-report-2022-focus-on-nutraceuticals-food-and-beverage-pharmaceutical-and-healthcare-cosmetics-and-personal-care-researchandmarkets-com/ 2022-11-14T19:12:07+00:00 https://medicaex.com/wp-content/uploads/2022/11/logo-kIdkOm.jpeg https://medicaex.com/businesswire/surgical-sphincteroplasty-global-market-report-2022-cost-effectiveness-of-sphincteroplasty-drives-growth-researchandmarkets-com-2/ 2022-11-14T18:12:13+00:00 https://medicaex.com/wp-content/uploads/2022/11/logo-Ixc5Se.jpeg https://medicaex.com/businesswire/surgical-sphincteroplasty-global-market-report-2022-cost-effectiveness-of-sphincteroplasty-drives-growth-researchandmarkets-com/ 2022-11-14T18:12:09+00:00 https://medicaex.com/wp-content/uploads/2022/11/logo-44QXXe.jpeg https://medicaex.com/businesswire/global-precision-medicine-market-report-2022-advancements-in-cancer-biologics-fuels-growth-researchandmarkets-com/ 2022-11-14T18:12:06+00:00 https://medicaex.com/wp-content/uploads/2022/11/logo-O5Bp7P.jpeg https://medicaex.com/businesswire/medica-foundation-supports-the-expansion-of-equitable-pediatric-mobile-care-to-underserved-families-across-the-region/ 2022-11-14T18:12:06+00:00 https://medicaex.com/wp-content/uploads/2022/11/Medica_Foundation_Logo_2022-gDkdQu.jpeg https://medicaex.com/businesswire/worldwide-cheminformatics-industry-to-2027-by-application-end-user-and-region-researchandmarkets-com/ 2022-11-14T18:12:05+00:00 https://medicaex.com/wp-content/uploads/2022/11/logo-CTPDkL.jpeg https://medicaex.com/businesswire/rising-toll-of-antibiotic-resistant-infections-costs-thousands-of-lives-and-billions-in-healthcare-dollars-annually-2/ 2022-11-14T17:12:12+00:00 https://medicaex.com/wp-content/uploads/2022/11/PFID_logo-PXwPke.jpeg https://medicaex.com/businesswire/syncell-to-present-at-sfns-neuroscience-2022-event-3/ 2022-11-14T17:12:11+00:00 https://medicaex.com/wp-content/uploads/2022/11/Logo_no_background-iZlqEg.jpeg https://medicaex.com/businesswire/global-restorative-dentistry-market-report-2022-analysis-competition-forecast-and-opportunities-2017-2021-2022-2027-researchandmarkets-com-2/ 2022-11-14T17:12:11+00:00 https://medicaex.com/wp-content/uploads/2022/11/logo-FW8aic.jpeg https://medicaex.com/businesswire/synthetic-biology-global-market-report-2022-demand-for-biofuel-presents-lucrative-opportunities-researchandmarkets-com-2/ 2022-11-14T17:12:11+00:00 https://medicaex.com/wp-content/uploads/2022/11/logo-RS7DYF.jpeg https://medicaex.com/businesswire/syncell-to-present-at-sfns-neuroscience-2022-event-2/ 2022-11-14T17:12:08+00:00 https://medicaex.com/wp-content/uploads/2022/11/Logo_no_background-GQU2C3.jpeg https://medicaex.com/businesswire/syncell-to-present-at-sfns-neuroscience-2022-event/ 2022-11-14T17:12:07+00:00 https://medicaex.com/wp-content/uploads/2022/11/Logo_no_background-wnt9lb.jpeg https://medicaex.com/businesswire/global-restorative-dentistry-market-report-2022-analysis-competition-forecast-and-opportunities-2017-2021-2022-2027-researchandmarkets-com/ 2022-11-14T17:12:07+00:00 https://medicaex.com/wp-content/uploads/2022/11/logo-agGjV7.jpeg https://medicaex.com/businesswire/rising-toll-of-antibiotic-resistant-infections-costs-thousands-of-lives-and-billions-in-healthcare-dollars-annually/ 2022-11-14T17:12:05+00:00 https://medicaex.com/wp-content/uploads/2022/11/PFID_logo-Aw0Q9y.jpeg https://medicaex.com/businesswire/us-anesthesia-drugs-and-devices-market-report-2022-growing-healthcare-expenditure-fueling-sector-researchandmarkets-com/ 2022-11-14T17:12:04+00:00 https://medicaex.com/wp-content/uploads/2022/11/logo-CKjZhX.jpeg https://medicaex.com/businesswire/synthetic-biology-global-market-report-2022-demand-for-biofuel-presents-lucrative-opportunities-researchandmarkets-com/ 2022-11-14T17:12:04+00:00 https://medicaex.com/wp-content/uploads/2022/11/logo-vbYzil.jpeg https://medicaex.com/businesswire/merit-awards-announces-winners-of-2022-technology-awards-2/ 2022-11-14T16:12:08+00:00 https://medicaex.com/businesswire/meditech-and-google-health-highlight-pilot-phase-collaboration-2/ 2022-11-14T16:12:07+00:00 https://medicaex.com/wp-content/uploads/2022/11/CARESTUDIO_V4_110922-myq6hM.jpeg https://medicaex.com/businesswire/meditech-and-google-health-highlight-pilot-phase-collaboration/ 2022-11-14T16:12:06+00:00 https://medicaex.com/wp-content/uploads/2022/11/CARESTUDIO_V4_110922-FfbmxG.jpeg https://medicaex.com/businesswire/walgreens-and-villagemd-expand-full-service-primary-care-practices-to-las-vegas/ 2022-11-14T16:12:04+00:00 https://medicaex.com/wp-content/uploads/2022/11/VillageMD_Logo_Stack_RGB_RT-Q6RJXb.jpeg https://medicaex.com/businesswire/merit-awards-announces-winners-of-2022-technology-awards/ 2022-11-14T16:12:03+00:00 https://medicaex.com/businesswire/global-tuberculosis-testing-market-report-2022-rising-the-prevalence-of-drug-resistant-tuberculosis-infection-driving-growth-researchandmarkets-com-2/ 2022-11-14T15:12:11+00:00 https://medicaex.com/wp-content/uploads/2022/11/logo-AySphN.jpeg https://medicaex.com/businesswire/mammoth-biosciences-named-in-biospaces-2023-best-places-to-work-2/ 2022-11-14T15:12:11+00:00 https://medicaex.com/wp-content/uploads/2022/11/Mammoth_Logo-mZQz48.jpeg https://medicaex.com/businesswire/wolters-kluwer-launches-digital-health-tech-solutions-for-payers-and-virtual-care-players/ 2022-11-14T15:12:09+00:00 https://medicaex.com/wp-content/uploads/2022/11/WK_Logo-NCAEqL.jpeg https://medicaex.com/businesswire/bamboo-health-announces-real-time-care-intelligence-tm-at-hlth-2022-ushering-in-a-new-era-of-insights-and-analytics-to-drive-whole-person-care/ 2022-11-14T15:12:09+00:00 https://medicaex.com/wp-content/uploads/2022/11/BambooHealth-Logo_Primary-Stacked-COLOR-OYDbto.jpeg https://medicaex.com/businesswire/gale-healthcare-named-global-health-tech-leader-2/ 2022-11-14T15:12:09+00:00 https://medicaex.com/wp-content/uploads/2022/11/Gale_logo-T93jpB.jpeg https://medicaex.com/businesswire/heru-continues-to-revolutionize-vision-care-surpassing-clinical-milestone-of-100000-eyes-examined-2/ 2022-11-14T15:12:09+00:00 https://medicaex.com/wp-content/uploads/2022/11/Heru_Logo-s1pjcc.jpeg https://medicaex.com/businesswire/timelymd-three-quarters-of-college-students-report-mental-health-boost-after-virtual-treatments-2/ 2022-11-14T15:12:08+00:00 https://medicaex.com/wp-content/uploads/2022/11/TimelyMD-Logo-Horz_28129-K523eb.jpeg https://medicaex.com/businesswire/heru-continues-to-revolutionize-vision-care-surpassing-clinical-milestone-of-100000-eyes-examined/ 2022-11-14T15:12:07+00:00 https://medicaex.com/wp-content/uploads/2022/11/Heru_Logo-FhLAVg.jpeg https://medicaex.com/businesswire/mammoth-biosciences-named-in-biospaces-2023-best-places-to-work/ 2022-11-14T15:12:05+00:00 https://medicaex.com/wp-content/uploads/2022/11/Mammoth_Logo-LpotgP.jpeg https://medicaex.com/businesswire/global-tuberculosis-testing-market-report-2022-rising-the-prevalence-of-drug-resistant-tuberculosis-infection-driving-growth-researchandmarkets-com/ 2022-11-14T15:12:05+00:00 https://medicaex.com/wp-content/uploads/2022/11/logo-hEvFm4.jpeg https://medicaex.com/businesswire/gale-healthcare-named-global-health-tech-leader/ 2022-11-14T15:12:04+00:00 https://medicaex.com/wp-content/uploads/2022/11/Gale_logo-SqSpgh.jpeg https://medicaex.com/businesswire/timelymd-three-quarters-of-college-students-report-mental-health-boost-after-virtual-treatments/ 2022-11-14T15:12:03+00:00 https://medicaex.com/wp-content/uploads/2022/11/TimelyMD-Logo-Horz_28129-NaZ0RE.jpeg https://medicaex.com/businesswire/groups-recover-together-implements-owl-labs-technology-to-make-distance-disappear-for-americans-struggling-with-substance-use-disorder/ 2022-11-14T15:12:03+00:00 https://medicaex.com/wp-content/uploads/2022/11/GroupsLogo_Standard-RsnE7m.jpeg https://medicaex.com/businesswire/twilio-unveils-segment-for-healthcare-life-sciences-to-break-down-data-silos-and-enable-proactive-customized-care-across-the-patient-journey-3/ 2022-11-14T14:12:19+00:00 https://medicaex.com/businesswire/tmd-lab-collaborates-with-us-nist-to-reveal-the-secrets-of-shape-memory-polymer-materials-2/ 2022-11-14T14:12:19+00:00 https://medicaex.com/wp-content/uploads/2022/11/Logo-X0jicO.jpeg https://medicaex.com/businesswire/persephone-biosciences-announces-last-participant-enrolled-in-my-baby-biome-study-of-infant-gut-health-2/ 2022-11-14T14:12:18+00:00 https://medicaex.com/businesswire/therapeutic-solutions-announces-universal-donor-myeloid-derived-suppressor-therapy-platform-for-treatment-of-chronic-obstructive-pulmonary-disease-copd-2/ 2022-11-14T14:12:18+00:00 https://medicaex.com/wp-content/uploads/2022/11/logo_tsoi-OqSksO.jpeg https://medicaex.com/businesswire/gicell-announces-the-preclinical-research-data-demonstrating-the-superiority-of-the-nk-cell-mass-culture-platform-at-the-society-for-immunotherapy-of-cancer/ 2022-11-14T14:12:18+00:00 https://medicaex.com/wp-content/uploads/2022/11/Photo-uDNM69.jpeg https://medicaex.com/businesswire/notable-survey-61-of-patients-skip-medical-appointments-due-to-scheduling-hassles/ 2022-11-14T14:12:15+00:00 https://medicaex.com/wp-content/uploads/2022/11/NotMeetingExpectationsBospar-M06iml.jpeg https://medicaex.com/businesswire/twilio-unveils-segment-for-healthcare-life-sciences-to-break-down-data-silos-and-enable-proactive-customized-care-across-the-patient-journey-2/ 2022-11-14T14:12:15+00:00 https://medicaex.com/businesswire/healee-launches-digital-care-pathways-at-hlth-2022-2/ 2022-11-14T14:12:14+00:00 https://medicaex.com/wp-content/uploads/2022/11/healee-transparent-logo-tT7lKT.jpeg https://medicaex.com/businesswire/braincheck-awarded-1-5m-grant-by-us-small-business-innovation-research-sbir-program-to-measure-effectiveness-of-digital-cognitive-care-management-platform/ 2022-11-14T14:12:14+00:00 https://medicaex.com/wp-content/uploads/2022/11/BrainCheck_logo-ZF3vUv.jpeg https://medicaex.com/businesswire/pointclickcare-announces-presence-at-hlth-to-accelerate-healthcare-innovation-2/ 2022-11-14T14:12:14+00:00 https://medicaex.com/wp-content/uploads/2022/11/PointClickCareLogoCMYK-BACHyL.jpeg https://medicaex.com/businesswire/vicarious-surgical-to-participate-in-upcoming-conferences/ 2022-11-14T14:12:12+00:00 https://medicaex.com/wp-content/uploads/2022/11/download-i2HEEx.jpeg https://medicaex.com/businesswire/clinical-chemistry-rapid-tests-and-poc-pipeline-report-including-stages-of-development-segments-region-and-countries-regulatory-path-and-key-companies-2022-update-researchandmarkets-com/ 2022-11-14T14:12:12+00:00 https://medicaex.com/wp-content/uploads/2022/11/logo-v9OMe3.jpeg https://medicaex.com/businesswire/tmd-lab-collaborates-with-us-nist-to-reveal-the-secrets-of-shape-memory-polymer-materials/ 2022-11-14T14:12:12+00:00 https://medicaex.com/wp-content/uploads/2022/11/Logo-U4rT1G.jpeg https://medicaex.com/businesswire/tivic-health-reports-third-quarter-2022-financial-results/ 2022-11-14T14:12:12+00:00 https://medicaex.com/wp-content/uploads/2022/11/Tivic_Health_Logo-fBUUn8.jpeg https://medicaex.com/businesswire/healee-launches-digital-care-pathways-at-hlth-2022/ 2022-11-14T14:12:11+00:00 https://medicaex.com/wp-content/uploads/2022/11/healee-transparent-logo-ZD5eNZ.jpeg https://medicaex.com/businesswire/twilio-unveils-segment-for-healthcare-life-sciences-to-break-down-data-silos-and-enable-proactive-customized-care-across-the-patient-journey/ 2022-11-14T14:12:07+00:00 https://medicaex.com/businesswire/code-biotherapeutics-names-alex-s-tracy-phd-as-chief-technical-officer/ 2022-11-14T14:12:07+00:00 https://medicaex.com/wp-content/uploads/2022/11/CodeBio_Logo-68Ltw9.jpeg https://medicaex.com/businesswire/genexa-introduces-new-cough-chest-congestion-medicine-for-adults-providing-consumers-with-a-clean-effective-choice-for-cold-flu-season/ 2022-11-14T14:12:06+00:00 https://medicaex.com/wp-content/uploads/2022/11/Genexa_Business_Wire_Image-dXuCh6.jpeg https://medicaex.com/businesswire/persephone-biosciences-announces-last-participant-enrolled-in-my-baby-biome-study-of-infant-gut-health/ 2022-11-14T14:12:06+00:00 https://medicaex.com/businesswire/therapeutic-solutions-announces-universal-donor-myeloid-derived-suppressor-therapy-platform-for-treatment-of-chronic-obstructive-pulmonary-disease-copd/ 2022-11-14T14:12:06+00:00 https://medicaex.com/wp-content/uploads/2022/11/logo_tsoi-5uRuAe.jpeg https://medicaex.com/businesswire/pointclickcare-announces-presence-at-hlth-to-accelerate-healthcare-innovation/ 2022-11-14T14:12:04+00:00 https://medicaex.com/wp-content/uploads/2022/11/PointClickCareLogoCMYK-6iyxYf.jpeg https://medicaex.com/businesswire/mvm-closes-oversubscribed-fund-at-500-million-hard-cap-2/ 2022-11-14T13:12:17+00:00 https://medicaex.com/wp-content/uploads/2022/11/MVM_white_logo_jpeg-bKRwJs.jpeg https://medicaex.com/businesswire/teva-announces-unique-collaboration-with-rimidi-to-expand-the-reach-of-its-respiratory-digital-health-platform-2/ 2022-11-14T13:12:17+00:00 https://medicaex.com/wp-content/uploads/2022/11/teva_RGB_JPEG-ratAz6.jpeg https://medicaex.com/businesswire/vbi-vaccines-to-participate-in-upcoming-investor-conferences-2/ 2022-11-14T13:12:17+00:00 https://medicaex.com/wp-content/uploads/2022/11/VBI_Vaccines_Logo_Horiz_RGB-B086Io.jpeg https://medicaex.com/businesswire/teva-announces-unique-collaboration-with-healthsnap-to-expand-the-reach-of-its-respiratory-digital-health-platform-4/ 2022-11-14T13:12:17+00:00 https://medicaex.com/wp-content/uploads/2022/11/teva_RGB_JPEG-UmyFgK.jpeg https://medicaex.com/businesswire/foxo-technologies-announces-agreement-with-haven-life/ 2022-11-14T13:12:17+00:00 https://medicaex.com/wp-content/uploads/2022/11/FOXO-Black-XC4laN.jpeg https://medicaex.com/businesswire/alice-zhang-ceo-co-founder-of-verge-genomics-recognized-today-by-both-fortune-and-fierce-biotech-as-a-pioneer-in-ai-driven-drug-discovery/ 2022-11-14T13:12:13+00:00 https://medicaex.com/wp-content/uploads/2022/11/Alice_Zhang_28129-He6Pt9.jpeg https://medicaex.com/businesswire/docgo-appoints-veteran-technology-human-resources-executive-vina-leite-ms-to-its-board-of-directors-and-announces-key-leadership-promotions-2/ 2022-11-14T13:12:13+00:00 https://medicaex.com/wp-content/uploads/2022/11/DocGo_Primaray_Logo_2022-RZydWo.jpeg